AI generated summary of Pubmed citation/abstract with PMID 38091574

https://pubmed.ncbi.nlm.nih.gov/38091574

In diffuse large B-cell lymphoma patients who can’t access CAR-T cell therapy, autologous hematopoietic cell transplantation after complete remission with bridging chemotherapy may lead to better outcomes.